These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22058188)

  • 1. Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start.
    Elborn JS
    Thorax; 2012 Jan; 67(1):4-5. PubMed ID: 22058188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protein repair therapy in cystic fibrosis].
    Clément A; Tamalet A; Fauroux B; Epaud R
    Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental paradigm for early features of cystic fibrosis.
    Larson JE; Cohen JC
    Pediatr Pulmonol; 2005 Nov; 40(5):371-7. PubMed ID: 15830387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis gene therapy trials and tribulations.
    Zeitlin PL
    Mol Ther; 2000 Jan; 1(1):5-6. PubMed ID: 10933904
    [No Abstract]   [Full Text] [Related]  

  • 5. [From the laboratory to the clinic: CFTR and the therapeutic options for cystic fibrosis].
    Mayol J; Alvarez de Arcaya Vicente A; Arbeo Escolar AM; Peña Soria MJ; Alvarez Fernández-Represa J
    An Med Interna; 2000 Feb; 17(2):92-8. PubMed ID: 10829466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
    Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
    J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correctors enhance maturation of DeltaF508 CFTR by promoting interactions between the two halves of the molecule.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2009 Oct; 48(41):9882-90. PubMed ID: 19761259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gene therapy of cystic fibrosis].
    Rochat T
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1779-83. PubMed ID: 10603652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From gene transfer to gene therapy in cystic fibrosis, how long is the road?].
    Bellon G
    Rev Prat; 1998 Jan; 48(1):5-8. PubMed ID: 9781203
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular repair of a defective CFTR protein in cystic fibrosis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2011 Apr; 35(4):254-6. PubMed ID: 21349786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cystic fibrosis and gene therapy].
    Setoguchi Y; Yokoyama T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
    Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
    Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    J Gene Med; 2001; 3(5):409-17. PubMed ID: 11601754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies to correct malfunction of CFTR.
    Lim M; Zeitlin PL
    Paediatr Respir Rev; 2001 Jun; 2(2):159-64. PubMed ID: 12531063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bithiazole correctors rescue CFTR mutants by two different mechanisms.
    Loo TW; Bartlett MC; Clarke DM
    Biochemistry; 2013 Aug; 52(31):5161-3. PubMed ID: 23865422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.
    Gelman MS; Kopito RR
    Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537
    [No Abstract]   [Full Text] [Related]  

  • 18. [Revolution in the treatment of cystic fibrosis].
    Sauty A; Plojoux J; Mornand A; Blanchon S; Koutsokera A
    Rev Med Suisse; 2020 Jun; 16(698):1229-1235. PubMed ID: 32558451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding cystic fibrosis, improving life expectancy.
    Bentley P
    Nurs Times; 1999 Oct 27-Nov 2; 95(43):50-1. PubMed ID: 10847084
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.